Table 5:
Descriptive characteristics of the study sample.
| Successful patient tracing | p-Value | ||
|---|---|---|---|
| No | Yes | ||
| (n=16,354) | (n=2,538) | ||
| n | n | ||
| Gender | |||
| Female & non-pregnanta | 9,946 (60.8) | 1,279 (50.4) | <0.001 |
| Female & pregnanta | 1,019 (6.2) | 328 (12.9) | |
| Male | 5,389 (33.0) | 931 (36.7) | |
| HIV status disclosed | |||
| No | 6,111 (37.4) | 861 (33.9) | 0.001 |
| Yes | 10,243 (62.6) | 1,677 (66.1) | |
| Travel time to clinic | |||
| <30′ | 4,122 (25.2) | 630 (24.8) | 0.015 |
| 30–59′ | 5,075 (31.0) | 861 (33.9) | |
| 1–2 h | 4,047 (24.7) | 612 (24.1) | |
| 2 + h | 3,110 (19.0) | 435 (17.1) | |
| Level of care | |||
| Primary | 5,004 (30.6) | 810 (31.9) | <0.001 |
| Secondary | 8,714 (53.3) | 1,253 (49.4) | |
| Tertiary | 2,636 (16.1) | 475 (18.7) | |
| Median (IQR) | Median (IQR) | p-Value | |
|---|---|---|---|
| Ageb, years | 36.0 (30.2, 42.9) | 36.5 (30.6, 43.6) | 0.007 |
| CD4b, cells/μL | 155 (84, 235) | 153 (81, 229) | 0.352 |
| Months on ART | 10.5 (2.9, 24.4) | 10.2 (2.9, 23.3) | 0.394 |
| Outreach worker ratioc (×100) | 5.0 (4.0, 5.9) | 5.0 (3.6, 5.9) | 0.003 |
aPrior to first loss to clinic bAt ART initiation. c# of outreach workers to total daily # of adult patients.